![]() Chien in 2010 and is headquartered in Cambridge, MA. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). For more information check our how to buy Moderna, Inc. stock price prediction is currently bullish. stock price is closed at $ 80.32 with a total market cap valuation of $ 30.62B ( 381.28M shares outstanding). The company's pipeline also includes a cell therapy-based treatment: a relaxin fusion protein being developed to treat acute decompensated heart failure.The Moderna, Inc. Transaction Type Share Price Shares Value Sale: Stephen Hoge President: Disposition 100. Candidates include possible vaccines for influenza, HIV, respiratory syncytial virus, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. 78.98 Delayed Data As of Nov 20 +2.54 / +3.32 Today’s Change 62.55 Today 52-Week Range 217.25 -56.03 Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs. company facts, information and financial ratios from MarketWatch. ![]() See the company's earnings, balance sheet, cash flow, share count and more. The company has 45 treatment and vaccine candidates, of which 38 have entered clinical trials. Get the latest Moderna Inc (MRNA) stock quote, charts, news and other financial information to help you make more informed trading and investment decisions. The company's only commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. ![]() The companys valuation now looks attractive in light of its growth opportunities. The company's name is derived from the terms "modified", "RNA", and "modern". Modernas share price has fallen significantly from the frothy days of 2021. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |